Oramed Pharmaceuticals, Inc. (ORMP)
4.62
-0.05
(-1.07%)
USD |
NASDAQ |
Sep 15, 16:00
4.625
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Price : 4.62 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 4.64 | 4.655 | 4.55 | 4.62 | 145851.0 |
| Sep 14, 2026 | 4.64 | 4.76 | 4.64 | 4.67 | 135097.0 |
| Sep 11, 2026 | 4.81 | 4.82 | 4.65 | 4.66 | 144534.0 |
| Sep 10, 2026 | 4.74 | 4.854 | 4.66 | 4.76 | 131469.0 |
| Sep 09, 2026 | 4.94 | 4.94 | 4.70 | 4.78 | 245686.0 |
| Sep 08, 2026 | 4.99 | 5.01 | 4.92 | 4.98 | 118174.0 |
| Sep 04, 2026 | 4.92 | 5.05 | 4.86 | 5.01 | 226874.0 |
| Sep 03, 2026 | 5.11 | 5.11 | 4.81 | 4.93 | 187972.0 |
| Sep 02, 2026 | 4.85 | 5.150 | 4.85 | 5.07 | 188607.0 |
| Sep 01, 2026 | 5.00 | 5.15 | 4.800 | 4.85 | 255346.0 |
| Aug 31, 2026 | 5.03 | 5.06 | 4.90 | 5.02 | 242855.0 |
| Aug 28, 2026 | 5.14 | 5.15 | 5.01 | 5.03 | 154133.0 |
| Aug 27, 2026 | 5.35 | 5.47 | 5.060 | 5.10 | 276400.0 |
| Aug 26, 2026 | 5.31 | 5.43 | 5.12 | 5.34 | 403560.0 |
| Aug 25, 2026 | 4.80 | 5.25 | 4.80 | 5.21 | 641502.0 |
| Aug 24, 2026 | 4.80 | 4.86 | 4.74 | 4.82 | 90739.00 |
| Aug 21, 2026 | 4.81 | 4.88 | 4.75 | 4.81 | 126130.0 |
| Aug 20, 2026 | 4.78 | 4.860 | 4.68 | 4.79 | 177177.0 |
| Aug 19, 2026 | 4.83 | 4.94 | 4.70 | 4.79 | 363167.0 |
| Aug 18, 2026 | 4.56 | 4.82 | 4.48 | 4.78 | 300901.0 |
| Aug 17, 2026 | 4.53 | 4.60 | 4.44 | 4.57 | 223942.0 |
| Aug 14, 2026 | 4.30 | 4.53 | 4.30 | 4.48 | 156769.0 |
| Aug 13, 2026 | 4.35 | 4.45 | 4.30 | 4.38 | 152016.0 |
| Aug 12, 2026 | 4.27 | 4.47 | 4.22 | 4.27 | 162886.0 |
| Aug 11, 2026 | 4.21 | 4.349 | 4.16 | 4.25 | 164148.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1136.11 |
| Pfizer Inc. | 27.55 |
| Liquidia Corp. | 65.72 |
| NRX Pharmaceuticals, Inc. | 3.40 |
| Scilex Holding Co. | 4.93 |
Price Related Metrics
| PE Ratio | 1.124 |
| Price to Book Value | 0.6012 |
| Earnings Yield | 88.97% |
| Market Cap | 190.87M |
| Normalized PE Ratio | 4.407 |